Skip to main content
. 2018 Jul 3;38(4):BSR20180580. doi: 10.1042/BSR20180580

Figure 2. Higher CXCL1 expression correlated with worse survival in patients with CRC.

Figure 2

(A) Five-year overall survival rates in patients with high or low expression of CXCL1 were 61.0 and 80.7%, respectively (X2 = 14.868, P<0.001). (B) Five-year disease-free survival rates in patients with high or low CXCL1 expression were 65.7 and 82.3%, respectively (X2 = 8.441, P=0.004).